Telehealth

Hims & Hers Health Reports Better-Than-Expected Q2 Results: Details
Teladoc Stock Falls Below 52-Week Lows On Q2 Earnings: Guidance Withdrawn On BetterHealth Weakness, 'Focused On Addressing The Work Ahead Of Us With Urgency'
Google, TikTok Ban Telehealth Firm's Ads For ADHD Medication Following Federal Crackdown
Teladoc Stock Falls Below 52-Week Lows On Q2 Earnings: Guidance Withdrawn On BetterHealth Weakness, 'Focused On Addressing The Work Ahead Of Us With Urgency'
Google, TikTok Ban Telehealth Firm's Ads For ADHD Medication Following Federal Crackdown
The Doctor Will See You Now... At Costco: Retailer Partners With Healthcare Startup
Psyched Business: Lobe Buys Rare Disease Treatment, Plus Healing CREI And Heally Team Up

Telehealth Recent News

At Home-Ketamine Therapy Platform: What's It All About?
Psychedelics mental wellness telehealth company Nue Life Health PBC is now offering Nue Care, a personalized six-month aftercare program to treat the root causes of mental health disorders with personal sessions, progress tracking, health coaching, integration support and supplements towards reducing the dependence on long-term pharmacotherapy.
'Teladoc Will Become A Premier Enterprise Partner': Why Cathie Wood Is Buying The Dip And Remains Bullish On Teladoc
Virtual healthcare provider Teladoc Health (NYSE: TDOC) has been a favorite stock pick of Cathie Wood, CEO of Ark Invest. After shares dropped 18% on Thursday from second quarter financial results, Wood defended the pick and bought the dip.
Cathie Wood Doubles Down On Telehealth Play With $15M Buy
Cathie Wood-led Ark Investment Management on Thursday bought the dip in shares of telehealth services provider Teladoc Health, Inc. (NYSE: TDOC).
At-Home Ketamine For Depression: New Study Adds Proof On Its Safety And Efficacy
Is At-Home Ketamine Treatment Safe For Patients?
Why Do Teladoc Health Investors Stand Divided? Bank Of America Analyst Weighs In
On July 10, Bank of America Corp (NYSE: BAC) analyst Allen Lutz published an analyst note on Teladoc Health, Inc (NYSE: TDOC).
CVS Stops Filling Controlled Substance Prescriptions From Two Telehealth Firms: Report
CVS Health Corp. (NYSE: CVS) has stopped filling prescriptions for controlled substances requested by clinicians from the telehealth startup companies Cerebral Inc. and Done Health.
Why Did A Canadian Healthcare Company Add $1.5M Shiba Inu To Its Balance Sheet?
Canadian healthcare company Ask The Doctor has added $1.5 million worth of Shiba Inu (CRYPTO: SHIB) to its balance sheet.
InvestorNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) Partners With Regional Primary Care Provider PeopleOne Health To Provide Digital Health Solutions
The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a financial partner of Benzinga.
Sponsored
Affinity Empowering Takes The 'Visit' Out Of 'Doctor's Visit'
No one likes visits to the doctor, and for good reason: It usually means that you're sick, you're missing work or you're going to be stranded in the waiting room. But what if you could take the visit out of your doctor's visit?
Sponsored
Cathie Wood Doubles Down On Teladoc, Spotify, Shopify As Stocks See Earnings-Related Dips
Cathie Wood-led Ark Investment Management on Wednesday piled up 713,842 shares, estimated to be worth about $108.37 million, in Teladoc Health Inc (NYSE: TDOC), a day after the telemedicine company
Hims & Hers Lands Miley Cyrus: Could The Stock Be A Party In The USA?
A telehealth and health and wellness company that recently went public announced a new deal with platinum artist Miley Cyrus.
Walmart Health Acquires Telehealth Provider MeMD
Walmart Health, a subsidiary of Walmart Inc. (NYSE: WMT), has acquired the Phoenix-headquartered telehealth provider MeMD for an undisclosed sum.
Exclusive: SmileDirect CFO Says Company 'Executing Very Well' On Long-Term Goals
SmileDirectClub, Inc. (NASDAQ: SDC) is an oral care company that embraces medical technology to provide affordable alternatives to expensive orthodontist services.
3 Stocks At 52-Week Lows That Could Bounce
An important indicator for investors to consider could be a stock's 52-week trading range, which shows the lowest and highest price at which a particular stock has traded over the last 52 weeks. Here is a look at three stocks at 52-week lows that could bounce.
Last Mile Telehealth Company Ambulnz Gets SPAC Deal: What Investors Should Know
A company specializing in last mile telehealth and medical mobility services is going public in a SPAC deal announced Tuesday.
Teladoc Health A 'Large Player In A Fast-Growing Market': Evercore ISI
Teladoc Health Inc (NYSE: TDOC) benefits from a first-mover advantage in telehealth and has been a beneficiary of the shift to virtual care during COVID-19, according to Evercore ISI.
12 New SPACs Filed Offerings On Friday: What Investors Should Know
A record 12 new SPACs filed offerings on Friday, Dec. 18. Here is a summary on the new offerings and what investors can expect.
Teladoc Falls On Amazon Telehealth Report: What Investors Should Know
Teladoc Health (NASDAQ: TDOC) is falling with news out that Amazon.com (NASDAQ: AMZN) is entering the telehealth space.
Fintech Focus For November 1, 2020
Chewy's Stock Gains On Launch Of Nationwide Telehealth Service For Pets
Shares of online pet store Chewy Inc (NYSE: CHWY) gained more than 5% after announcing a nationwide expansion of a new telehealth service for pets.
How Conversion Labs Is Building Its Telemedicine Business During COVID-19
Interest in telemedicine has soared during the coronavirus pandemic as health care patients sought continuity during the crisis by going virtual, said 
Khiron Continues Cross-Border Expansion, Adapts To 'Low Touch Economy'
In an effort to expand across Latin America, Khiron Life Sciences Corp. (OTCQX: KHRNF) recently partnered with e-commerce company Rappi to launch and distribute a line of CBD products to Uruguay and Costa Rica.
GoodRx Holdings IPO: What Investors Need To Know
Prescription pricing platform GoodRx Holdings will hit the public markets this week.

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga

© 2024 Benzinga | All Rights Reserved